IBDEI1F6 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22962,1,3,0)
 ;;=3^Atopic Dermatitis
 ;;^UTILITY(U,$J,358.3,22962,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,22962,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,22963,0)
 ;;=L25.9^^76^992^15
 ;;^UTILITY(U,$J,358.3,22963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22963,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,22963,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,22963,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,22964,0)
 ;;=L40.0^^76^992^16
 ;;^UTILITY(U,$J,358.3,22964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22964,1,3,0)
 ;;=3^Psoriasis
 ;;^UTILITY(U,$J,358.3,22964,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,22964,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,22965,0)
 ;;=L29.9^^76^992^17
 ;;^UTILITY(U,$J,358.3,22965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22965,1,3,0)
 ;;=3^Pruritus
 ;;^UTILITY(U,$J,358.3,22965,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,22965,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,22966,0)
 ;;=L85.3^^76^992^18
 ;;^UTILITY(U,$J,358.3,22966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22966,1,3,0)
 ;;=3^Xerosis
 ;;^UTILITY(U,$J,358.3,22966,1,4,0)
 ;;=4^L85.3
 ;;^UTILITY(U,$J,358.3,22966,2)
 ;;=^5009323
 ;;^UTILITY(U,$J,358.3,22967,0)
 ;;=L30.2^^76^992^19
 ;;^UTILITY(U,$J,358.3,22967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22967,1,3,0)
 ;;=3^Cutaneous Autosensitization/ld
 ;;^UTILITY(U,$J,358.3,22967,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,22967,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,22968,0)
 ;;=L72.0^^76^992^20
 ;;^UTILITY(U,$J,358.3,22968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22968,1,3,0)
 ;;=3^Epidermal Cyst
 ;;^UTILITY(U,$J,358.3,22968,1,4,0)
 ;;=4^L72.0
 ;;^UTILITY(U,$J,358.3,22968,2)
 ;;=^5009277
 ;;^UTILITY(U,$J,358.3,22969,0)
 ;;=L73.9^^76^992^21
 ;;^UTILITY(U,$J,358.3,22969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22969,1,3,0)
 ;;=3^Follicular Disorder/Folliculitis
 ;;^UTILITY(U,$J,358.3,22969,1,4,0)
 ;;=4^L73.9
 ;;^UTILITY(U,$J,358.3,22969,2)
 ;;=^5009286
 ;;^UTILITY(U,$J,358.3,22970,0)
 ;;=L70.0^^76^992^22
 ;;^UTILITY(U,$J,358.3,22970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22970,1,3,0)
 ;;=3^Acne
 ;;^UTILITY(U,$J,358.3,22970,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,22970,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,22971,0)
 ;;=L71.8^^76^992^23
 ;;^UTILITY(U,$J,358.3,22971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22971,1,3,0)
 ;;=3^Rosacea
 ;;^UTILITY(U,$J,358.3,22971,1,4,0)
 ;;=4^L71.8
 ;;^UTILITY(U,$J,358.3,22971,2)
 ;;=^5009275
 ;;^UTILITY(U,$J,358.3,22972,0)
 ;;=L91.0^^76^992^24
 ;;^UTILITY(U,$J,358.3,22972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22972,1,3,0)
 ;;=3^Hypertrophic Scar
 ;;^UTILITY(U,$J,358.3,22972,1,4,0)
 ;;=4^L91.0
 ;;^UTILITY(U,$J,358.3,22972,2)
 ;;=^5009459
 ;;^UTILITY(U,$J,358.3,22973,0)
 ;;=L91.8^^76^992^25
 ;;^UTILITY(U,$J,358.3,22973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22973,1,3,0)
 ;;=3^Skin Tag/Oth Hypertrophic Disorder of Skin
 ;;^UTILITY(U,$J,358.3,22973,1,4,0)
 ;;=4^L91.8
 ;;^UTILITY(U,$J,358.3,22973,2)
 ;;=^5009460
 ;;^UTILITY(U,$J,358.3,22974,0)
 ;;=I87.2^^76^992^26
 ;;^UTILITY(U,$J,358.3,22974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22974,1,3,0)
 ;;=3^Stasis Dermatitis/Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,22974,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,22974,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,22975,0)
 ;;=D69.8^^76^992^27
 ;;^UTILITY(U,$J,358.3,22975,1,0)
 ;;=^358.31IA^4^2
